Application of Nanotechnology in Cosmetics
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The National Nanotechnology Initiative (NNI), established in 2001 to coordinate Federal nanotechnology research and development, defines nanotechnology as i) research and technology development at the atomic, molecular, or macromolecular levels in the length scale of approximately the 1- to 100-nanometer range; ii) creating and using structures, devices, and systems that have novel properties and functions because of their small and/or intermediate size; and iii) the ability to control or manipulate on the atomic scale (1). Generally speaking, nanotechnology can be defined as the application of scientific and engineering principles to make and utilize very small things. Nanotechnology is moving into the centre of world-wide public attention because of its broad range of applications which could dramatically impact both the scientific community and the commercial marketplace. Nanotechnology applications have been applied across biomedical, optical, electronic, mechanical, an
- The US National Nanotechnology Initiative (NNI). http://www.nano.gov/html/about/home_about.html.
- Buzea C, Pacheco Blandino II, Robbie K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases. 2007;2(4):MR17–172. CrossRef
- Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline from studies of ultrafine particles. Environ Health Perspect. 2005;113(7):823–39. CrossRef
- Ryman-Rasmussen JP, Cesta MF, Brody AR, Shipley-Phillips JK, Everitt JI, Tewksbury EW et al. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nano. 2009;4:747–51. CrossRef
- U.S. Food and Drug Administration, Nanotechnology Task Force Report. July 2007. http://www/fda.gov/nanotechnology/taskforce/report2007.html.
- Padamwar MN, Pokharkar VB. Development of vitamin loaded liposomal formulations using factorial design approach: drug deposition and stability. Int J Pharm. 2006;320:37–44. CrossRef
- Touitou E, Junginger HE, Weiner ND, Nagai T, Mezei M. Liposomes as carriers for topical and transdermal delivery. J Pharm Sci. 1994;83(9):1189–203. CrossRef
- Lens M. Use of fullerenes in cosmetics. Recent Patents on Biotechnology. 2009;3:118–23. CrossRef
- Petersen R. Nanocrystals for use in topical cosmetic formulations and method of production thereof. Abbott GmbH & Co. US Patent 60/866233 (2008).
- L’Oréal. Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics. US Patent 6432423, (2002).
- Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170–84. CrossRef
- Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59:427–43. CrossRef
- Villalobos-Hernàndez JR, Müller-Goymann CC. Sun protection enhancement of titanium dioxide crystals by the use of carnauba wax nanoparticles: The synergistic interaction between organic and inorganic sunscreens at nanoscale. Int J Pharm. 2006;322:161–70. CrossRef
- Friends of the Earth. http://www.foe.org. Nanomaterials, sunscreens and cosmetics: Small Ingredients, Big Risks, (2006).
- Mavon A, Miquel C, Lejeune O, Payre B, Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol. 2007;20:10–20. CrossRef
- Jowsey IR, Basketter DA, Westmoreland C, Kimber IA. A future approach to measuring relative skin sensitising potential: a proposal. J Appl Toxicol. 2006;26(4):341–50. CrossRef
- Application of Nanotechnology in Cosmetics
Volume 27, Issue 8 , pp 1746-1749
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Industry Sectors